Role of peptide transporter PEPT1 in the intestinal absorption and pharmacokinetics of the amino acid ester prodrug valacyclover

作者: Bei Yang

DOI:

关键词:

摘要: Purpose. The study evaluated the quantitative contribution of PEPT1 to intestinal permeability valacyclovir, an ester prodrug antiviral drug acyclovir. Methods. Valacyclovir effective (Peff) was examined by in situ single-pass perfusion studies performed wildtype and Pept1 knockout mice. In particular, valacyclovir Peff measured as a function perfusate pH, potential inhibitors, concentrations segments under steady-state conditions. calculated as: = -Q×ln(Cout/Cin)/(2πRL), after correcting for water flux with gravimetric method well luminal degradation. At end procedures, portal vein plasma samples were collected analyzed determine extent bioconversion valacyclovir. All using validated HPLC coupled fluorescence detection. Results. jejunal mice significantly inhibited glycylsarcosine cefadroxil, suggesting PEPT1-specific active uptake kinetics jejunum fitted major Michaelis– 39 Menten term (apparent affinity constant Km=10 mM) minor linear term. values comparably high duodenum, ileum substantial lower colon mice, finding consistent not being expressed large intestine. small reduced about 90% compared that different from Peff. No significant differences observed between two genotypes. Jejunal also insensitive changes pH over range 5.5 7.5. samples, only acyclovir detected while levels below limit Conclusions. Our findings demonstrate accounted approximately mouse Other membrane transporters appeared play role, if any, facilitating absorption rapidly completely converted acyclovir, current conditions, passing wall.

参考文章(108)
Mei‐Ling Chen, An alternative approach for assessment of rate of absorption in bioequivalence studies. Pharmaceutical Research. ,vol. 9, pp. 1380- 1385 ,(1992) , 10.1023/A:1015842425553
Frederick H. Leibach, Dale E. Bockman, Vadivel Ganapathy, Thomas G. Oblak, Localization of peptide transporter in nuclei and lysosomes of the pancreas. International Journal of Pancreatology. ,vol. 22, pp. 221- 225 ,(1997) , 10.1007/BF02788388
Hideyuki Motohashi, Toshiya Katsura, Hideyuki Saito, Ken‐ichi Inui, Effects of tacrolimus and cyclosporin a on peptide transporter PEPT1 in caco-2 cells Pharmaceutical Research. ,vol. 18, pp. 713- 717 ,(2001) , 10.1023/A:1011006015593
George W. Hartmann, Precision and Accuracy ,(2011)
Yasuhisa Adachi, Hiroshi Suzuki, Yuichi Sugiyama, Quantitative evaluation of the function of small intestinal P-glycoprotein: comparative studies between in situ and in vitro. Pharmaceutical Research. ,vol. 20, pp. 1163- 1169 ,(2003) , 10.1023/A:1025088628787
Hyo‐kyung Han, Remco L. A. de Vrueh, Julie K. Rhie, Kuang‐Ming Y. Covitz, Philip L. Smith, Chao‐Pin Lee, Doo‐Man Oh, Wolfgang Sadee, Gordon L. Amidon1, 5′-Amino Acid Esters of Antiviral Nucleosides, Acyclovir, and AZT Are Absorbed by the Intestinal PEPT1 Peptide Transporter Pharmaceutical Research. ,vol. 15, pp. 1154- 1159 ,(1998) , 10.1023/A:1011919319810
Rong Liang, You-Jun Fei, Puttur D. Prasad, Sammanda Ramamoorthy, Hong Han, Teresa L. Yang-Feng, Matthias A. Hediger, Vadivel Ganapathy, Frederick H. Leibach, Human Intestinal H+/Peptide Cotransporter Journal of Biological Chemistry. ,vol. 270, pp. 6456- 6463 ,(1995) , 10.1074/JBC.270.12.6456
Kem C. Meadows, Jennifer B. Dressman, Mechanism of acyclovir uptake in rat jejunum. Pharmaceutical Research. ,vol. 7, pp. 299- 303 ,(1990) , 10.1023/A:1015890516119
David T Thwaites, Catriona MH Anderson, The SLC36 family of proton-coupled amino acid transporters and their potential role in drug transport. British Journal of Pharmacology. ,vol. 164, pp. 1802- 1816 ,(2011) , 10.1111/J.1476-5381.2011.01438.X